Literature DB >> 19036819

MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.

Martin Baril1, Marie-Eve Racine, François Penin, Daniel Lamarre.   

Abstract

The mitochondrial antiviral signaling (MAVS) protein plays a central role in innate antiviral immunity. Upon recognition of a virus, intracellular receptors of the RIG-I-like helicase family interact with MAVS to trigger a signaling cascade. In this study, we investigate the requirement of the MAVS structure for enabling its signaling by structure-function analyses and resonance energy transfer approaches in live cells. We now report the essential role of the MAVS oligomer in signal transduction and map the transmembrane domain as the main determinant of dimerization. A combination of mutagenesis and computational methods identified a cluster of residues making favorable van der Waals interactions at the MAVS dimer interface. We also correlated the activation of IRF3 and NF-kappaB with MAVS oligomerization rather than its mitochondrial localization. Finally, we demonstrated that MAVS oligomerization is disrupted upon expression of HCV NS3/4A protease, suggesting a mechanism for the loss of antiviral signaling. Altogether, our data suggest that the MAVS oligomer is essential in the formation of a multiprotein membrane-associated signaling complex and enables downstream activation of IRF3 and NF-kappaB in antiviral innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036819      PMCID: PMC2620913          DOI: 10.1128/JVI.01659-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

2.  A study of the membrane-water interface region of membrane proteins.

Authors:  Erik Granseth; Gunnar von Heijne; Arne Elofsson
Journal:  J Mol Biol       Date:  2004-12-13       Impact factor: 5.469

3.  The apoptosome activates caspase-9 by dimerization.

Authors:  Cristina Pop; John Timmer; Sabina Sperandio; Guy S Salvesen
Journal:  Mol Cell       Date:  2006-04-21       Impact factor: 17.970

4.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

5.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

6.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

7.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

8.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.

Authors:  Yueh-Ming Loo; David M Owen; Kui Li; Andrea K Erickson; Cynthia L Johnson; Penny M Fish; D Spencer Carney; Ting Wang; Hisashi Ishida; Mitsutoshi Yoneyama; Takashi Fujita; Takeshi Saito; William M Lee; Curt H Hagedorn; Daryl T-Y Lau; Steven A Weinman; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

10.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

View more
  88 in total

Review 1.  Induction and evasion of innate antiviral responses by hepatitis C virus.

Authors:  Stanley M Lemon
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Mitochondria and antiviral innate immunity.

Authors:  Takumi Koshiba; Nasir Bashiruddin; Shunichiro Kawabata
Journal:  Int J Biochem Mol Biol       Date:  2011-08-15

3.  A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Authors:  Suzanne Paz; Myriam Vilasco; Steven J Werden; Meztli Arguello; Deshanthe Joseph-Pillai; Tiejun Zhao; Thi Lien-Anh Nguyen; Qiang Sun; Eliane F Meurs; Rongtuan Lin; John Hiscott
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

Review 4.  Sensing of viral nucleic acids by RIG-I: from translocation to translation.

Authors:  Andreas Schmidt; Simon Rothenfusser; Karl-Peter Hopfner
Journal:  Eur J Cell Biol       Date:  2011-04-14       Impact factor: 4.492

Review 5.  Regulation of hepatic innate immunity by hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

6.  MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltage-dependent anion channel 1.

Authors:  Kai Guan; Zirui Zheng; Ting Song; Xiang He; Changzhi Xu; Yanhong Zhang; Shengli Ma; Ying Wang; Quanbin Xu; Ye Cao; Jia Li; Xiaoli Yang; Xiaoxing Ge; Congwen Wei; Hui Zhong
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

7.  Regulation of mitochondrial antiviral signaling (MAVS) expression and signaling by the mitochondria-associated endoplasmic reticulum membrane (MAM) protein Gp78.

Authors:  Jana L Jacobs; Jianzhong Zhu; Saumendra N Sarkar; Carolyn B Coyne
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

Review 8.  Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.

Authors:  Man Yu; Stewart J Levine
Journal:  Cytokine Growth Factor Rev       Date:  2011-04-03       Impact factor: 7.638

9.  Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression.

Authors:  Anton Soucy-Faulkner; Espérance Mukawera; Karin Fink; Alexis Martel; Loubna Jouan; Yves Nzengue; Daniel Lamarre; Christine Vande Velde; Nathalie Grandvaux
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

10.  The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.

Authors:  Peyman Nakhaei; Thibault Mesplede; Mayra Solis; Qiang Sun; Tiejun Zhao; Long Yang; Tsung-Hsien Chuang; Carl F Ware; Rongtuan Lin; John Hiscott
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.